花园生物：全资子公司产品阿仑膦酸钠片中选本次国家集采

Group 1 - Garden Biologics announced that its subsidiary, Zhejiang Garden Pharmaceutical Co., Ltd., won the bid for Alendronate Sodium Tablets in the 11th batch of national centralized drug procurement [1] - For the year 2024, the revenue composition of Garden Biologics is projected to be 65.08% from vitamins and 34.92% from the pharmaceutical manufacturing sector [1] - As of the report, the market capitalization of Garden Biologics is 7.5 billion yuan [1]